Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

Yara Abdou, William E Barlow, Julie R Gralow, Funda Meric-Bernstam, Kathy S Albain, Daniel F Hayes, Nancy U Lin, Edith A Perez, Lori J Goldstein, Stephen K L Chia, Sukhbinder Dhesy-Thind, Priya Rastogi, Emilio Alba, Suzette Delaloge, Anne F Schott, Steven Shak, Priyanka Sharma, Danika L Lew, Jieling Miao, Joseph M Unger, Debasish Tripathy, Gabriel N Hortobagyi, Lajos Pusztai, Kevin Kalinsky

Open source

DOI: 10.1093/jnci/djae314
Published: 2024-12-05
Container: JNCI: Journal of the National Cancer Institute
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jnci/djae314,
  title = {Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial},
  author = {Yara Abdou and William E Barlow and Julie R Gralow and Funda Meric-Bernstam and Kathy S Albain and Daniel F Hayes and Nancy U Lin and Edith A Perez and Lori J Goldstein and Stephen K L Chia and Sukhbinder Dhesy-Thind and Priya Rastogi and Emilio Alba and Suzette Delaloge and Anne F Schott and Steven Shak and Priyanka Sharma and Danika L Lew and Jieling Miao and Joseph M Unger and Debasish Tripathy and Gabriel N Hortobagyi and Lajos Pusztai and Kevin Kalinsky},
  year = {2024},
  journal = {JNCI: Journal of the National Cancer Institute},
  doi = {10.1093/jnci/djae314},
  url = {https://doi.org/10.1093/jnci/djae314}
}

RIS

TY  - JOUR
TI  - Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial
AU  - Yara Abdou
AU  - William E Barlow
AU  - Julie R Gralow
AU  - Funda Meric-Bernstam
AU  - Kathy S Albain
AU  - Daniel F Hayes
AU  - Nancy U Lin
AU  - Edith A Perez
AU  - Lori J Goldstein
AU  - Stephen K L Chia
AU  - Sukhbinder Dhesy-Thind
AU  - Priya Rastogi
AU  - Emilio Alba
AU  - Suzette Delaloge
AU  - Anne F Schott
AU  - Steven Shak
AU  - Priyanka Sharma
AU  - Danika L Lew
AU  - Jieling Miao
AU  - Joseph M Unger
AU  - Debasish Tripathy
AU  - Gabriel N Hortobagyi
AU  - Lajos Pusztai
AU  - Kevin Kalinsky
PY  - 2024
JO  - JNCI: Journal of the National Cancer Institute
DO  - 10.1093/jnci/djae314
UR  - https://doi.org/10.1093/jnci/djae314
ER  -

APA

Abdou, Y., Barlow, W. E., Gralow, J. R., Meric-Bernstam, F., Albain, K. S., Hayes, D. F., Lin, N. U., Perez, E. A., Goldstein, L. J., Chia, S. K. L., Dhesy-Thind, S., Rastogi, P., Alba, E., Delaloge, S., Schott, A. F., Shak, S., Sharma, P., Lew, D. L., Miao, J., Unger, J. M., Tripathy, D., Hortobagyi, G. N., Pusztai, L., & Kalinsky, K. (2024). Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae314

Source records

crossref · retrieved 2026-09-26T07:53:04.188Z